Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CRON Cronos Group Inc
- Stocks
- Healthcare
- NASDAQ: CRON
Price (delayed)
$1.91
Market cap
$736.15M
P/E Ratio
13.64
Dividend/share
N/A
EPS
$0.14
Enterprise value
-$60.69M
Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology
Highlights
Cronos Group's EPS has surged by 200% YoY and by 27% QoQ
The net income has surged by 187% year-on-year and by 20% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://thecronosgroup.com
Key stats
What are the main financial stats of CRON
Market
Valuations
Earnings
Shares outstanding
385.42M
Market cap
$736.15M
Enterprise value
-$60.69M
Price to earnings (P/E)
13.64
Price to book (P/B)
0.69
Price to sales (P/S)
5.86
EV/EBIT
N/A
EV/EBITDA
-6.66
EV/Sales
-0.49
Revenue
$124.59M
Gross profit
$34.45M
Operating income
-$64.65M
Net income
$49.44M
EBIT
-$1.33M
EBITDA
$9.12M
Free cash flow
-$6.99M
Per share
Balance sheet
Liquidity
EPS
$0.14
EPS diluted
$0.14
Free cash flow per share
-$0.02
Book value per share
$2.79
Revenue per share
$0.33
TBVPS
$2.82
Total assets
$1.15B
Total liabilities
$39.06M
Debt
$977,000
Equity
$1.07B
Working capital
$885.53M
Debt to equity
0
Current ratio
27.8
Quick ratio
26.16
Net debt/EBITDA
-87.41
Margins
Efficiency
Dividend
EBITDA margin
7.3%
Gross margin
27.7%
Net margin
39.7%
Operating margin
-51.9%
Return on assets
4.3%
Return on equity
4.6%
Return on invested capital
-0.6%
Return on capital employed
-0.1%
Return on sales
-1.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CRON stock price
How has the Cronos Group stock price performed over time
Intraday
1.06%
1 week
0%
1 month
-5.91%
1 year
-17.67%
YTD
-5.45%
QTD
5.52%
Financial performance
How have Cronos Group's revenue and profit performed over time
Revenue
$124.59M
Gross profit
$34.45M
Operating income
-$64.65M
Net income
$49.44M
Gross margin
27.7%
Net margin
39.7%
The net income has surged by 187% year-on-year and by 20% since the previous quarter
The company's net margin has surged by 165% YoY and by 14% QoQ
Cronos Group's gross profit has soared by 156% YoY and by 37% from the previous quarter
The company's gross margin has surged by 91% YoY and by 29% QoQ
Price vs fundamentals
How does CRON's price correlate with its fundamentals
Growth
What is Cronos Group's growth rate over time
Valuation
What is Cronos Group stock price valuation
P/E
13.64
P/B
0.69
P/S
5.86
EV/EBIT
N/A
EV/EBITDA
-6.66
EV/Sales
-0.49
Cronos Group's EPS has surged by 200% YoY and by 27% QoQ
The price to book (P/B) is 31% lower than the 5-year quarterly average of 1.0
The price to sales (P/S) is 75% lower than the 5-year quarterly average of 23.8 and 17% lower than the last 4 quarters average of 7.1
Cronos Group's revenue has increased by 34% YoY and by 6% QoQ
Efficiency
How efficient is Cronos Group business performance
CRON's ROE has soared by 190% YoY and by 21% QoQ
The company's return on assets has surged by 186% YoY and by 19% QoQ
Cronos Group's return on sales has surged by 99% YoY and by 91% QoQ
The company's return on invested capital has surged by 98% YoY and by 91% QoQ
Dividends
What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CRON.
Financial health
How did Cronos Group financials performed over time
The company's quick ratio rose by 48% QoQ
Cronos Group's current ratio has increased by 48% from the previous quarter
The company's debt is 100% lower than its equity
The company's debt fell by 4.7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.